300138 晨光生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.13014.46014.58914.49714.046
总资产报酬率 ROA (%)0.4386.2056.7406.6265.845
投入资产回报率 ROIC (%)0.4646.6327.1787.0016.324

边际利润分析
销售毛利率 (%)8.20811.61213.94114.75516.663
营业利润率 (%)2.5607.9807.7357.8977.949
息税前利润/营业总收入 (%)3.8008.7788.3319.2109.815
净利润/营业总收入 (%)1.9057.1926.9277.1946.801

收益指标分析
经营活动净收益/利润总额(%)102.29875.69091.13987.39593.685
价值变动净收益/利润总额(%)-13.77013.3166.6677.7713.816
营业外收支净额/利润总额(%)-0.2061.3482.9393.3150.502

偿债能力分析
流动比率 (X)1.6081.6111.7871.4832.042
速动比率 (X)0.8800.8021.0490.6520.785
资产负债率 (%)62.35558.63753.57953.2610.558
带息债务/全部投入资本 (%)58.78554.31248.14847.29249.999
股东权益/带息债务 (%)66.39879.749101.822104.45393.752
股东权益/负债合计 (%)59.37269.30885.31387.82179.545
利息保障倍数 (X)3.05212.73723.0638.8385.377

营运能力分析
应收账款周转天数 (天)23.58120.08719.92325.43626.964
存货周转天数 (天)179.043155.053141.589174.224204.928